ArticleBMC infectious diseases2026
Targeted epidemic mitigation through age-specific dose-response recovery modeling.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study develops an age–stratified SEIR framework with dose–dependent recovery to explore how therapeutic allocation across age groups can mitigate epidemic spread. The susceptible and exposed classes are modeled as a single homogeneous pool, while infectious and recovered individuals are partitioned into four age groups (infants, children, adolescents, adults) with distinct recovery rates. Recovery in each age class is governed by a sigmoid dose–response relationship, representing age–specific pharmacodynamic efficacy as a function of administered dose. We derive an explicit expression for the basic reproduction number [Formula: see text], identify the corresponding transmission threshold [Formula: see text], and characterize the forward threshold at [Formula: see text] separating disease-free extinction from transient epidemic waves with age-stratified quasi-steady plateaus. Numerical simulations, including time series and low–dimensional phase portraits, illustrate how improving recovery in high–contribution age groups (particularly infants and children) can reduce [Formula: see text] and suppress epidemic peaks under a range of initial conditions. The results provide a conceptual quantitative framework for assessing age–specific dosing strategies and highlight the need for disease – and setting–specific calibration before drawing operational policy conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.